Based on the iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) stock forecast from 0 analysts, the average analyst target price for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) is not available over the next 12 months. iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) is Very Bearish, which is based on 0 positive signals and 3 negative signals. At the last closing, iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)’s stock price was EUR 6.05. iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)’s stock price has changed by -1.45% over the past week, -1.56% over the past month and +10.02% over the last year.
No recent analyst target price found for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
No recent average analyst rating found for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Company Overview iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index. Read Less
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.
Frequently Asked Questions About iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (2B70:XETRA) Stock
Stock Target Advisor's fundamental analysis for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)'s stock is Very Bearish.
2B70:XETRA stock's dividend yield is 0.87%.
Our analysis grades 2B70:XETRA stock's dividend yield at F. This means that 2B70:XETRA stock's dividend yield is above 6% of the stocks in the Others sector in the XETRA exchange.
Based on this 2B70:XETRA may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on 2B70:XETRA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 2B70:XETRA's stock to indicate if its overvalued.
The last closing price of 2B70:XETRA's stock was EUR 6.05.
The most recent market capitalization for 2B70:XETRA is EUR 0.52B.
Unfortunately we do not have enough analyst data on 2B70:XETRA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)'s stock.
Sorry, we do not have any data on the number of employees for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc).
Sorry we do not have any infomation available on iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)'s address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Frequently Asked Questions About iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (2B70:XETRA) Stock
Stock Target Advisor's fundamental analysis for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)'s stock is Very Bearish.
2B70:XETRA stock's dividend yield is 0.87%.
Our analysis grades 2B70:XETRA stock's dividend yield at F. This means that 2B70:XETRA stock's dividend yield is above 6% of the stocks in the Others sector in the XETRA exchange.
Based on this 2B70:XETRA may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on 2B70:XETRA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 2B70:XETRA's stock to indicate if its overvalued.
The last closing price of 2B70:XETRA's stock was EUR 6.05.
The most recent market capitalization for 2B70:XETRA is EUR 0.52B.
Unfortunately we do not have enough analyst data on 2B70:XETRA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)'s stock.
Sorry, we do not have any data on the number of employees for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc).
Sorry we do not have any infomation available on iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)'s address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 2B70:XETRA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
